Regeneron Pharmaceuticals target price raised to $1,050 from $920
REGN•BMO raised its target price for Regeneron Pharmaceuticals to $1,050 from $920.
Related News
Innventure board forms strategic review committee to evaluate capital strategies
INV•
FDA to review uniQure's Huntington's gene therapy, decision due May 1, 2027
QURE•
SEALSQ hosts Quantum Days event on post-quantum security
LAES•
B. Riley raises Roblox target price to $51 from $45
RBLX•
Acadia Realty Trust Q3 revenue beats estimates, FFO rises
AKR•